Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01473771 · ClinicalTrials.gov registry record · NA
Caring Letters for Military Suicide Prevention
A NA study, sponsored by National Center for Telehealth and Technology.
- Completed
- Registry status
- NA
- Development phase
- 1,319
- Enrollment target
NCT01473771 is a NA study that has completed, run by National Center for Telehealth and Technology. The registered enrollment target is 1,319 participants.
The verdict
NCT01473771, a NA study, has completed, sponsored by National Center for Telehealth and Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,319 participants
- Enrollment target
Study Summary
The purpose of this multi-site randomized controlled trial is to determine if the Caring Letters intervention is effective in preventing suicide and suicidal behaviors among U.S. Service Members and Veterans. The primary aim of this project is determine whether caring communications following inpatient psychiatric treatment reduce suicide and self-inflicted injuries among U.S. military personnel and Veterans. The investigators will also explore treatment utilization by comparing the frequency of treatment visits after enrollment into the study. The following specific hypotheses will be tested: Hypothesis 1: During a two year follow-up after the index hospital discharge, the frequency of suicide will be lower among participants in the Caring Letters group compared to those in the Usual Care group. Hypothesis 2: The frequency of medically admitted self-inflicted injuries will also be lower in the Caring Letters group compared to the Usual Care group. Hypothesis 3: The time to suicidal act, among those who do subsequently exhibit one, will be longer among participants in the Caring Letters group compared to the Usual Care group.
Interventions
- BEHAVIORAL Caring Letter (email)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,319 participants |
| Start Date | 2011-11 |
| Est. Completion | 2018-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01473771
The ClinicalTrials.gov registry entry for NCT01473771 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,319 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Telehealth and Technology, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Caring Letter (email) is the first listed.
NCT01473771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01473771 about?
NCT01473771 is a clinical study titled "Caring Letters for Military Suicide Prevention". The purpose of this multi-site randomized controlled trial is to determine if the Caring Letters intervention is effective in preventing suicide and suicidal behaviors among U.S. Service Members and Veterans. The primary aim of this project is determine whether caring communications following inpati...
What is the current status of trial NCT01473771?
This trial is currently completed. It is a NA study. The enrollment target is 1,319 participants. The study started on 2011-11. Estimated completion is 2018-08.
What interventions are being tested in trial NCT01473771?
The interventions under investigation include: Caring Letter (email) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01473771?
This trial is sponsored by National Center for Telehealth and Technology, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.